More money is being injected into the telehealth space in Europe. Zava, a long-time player that bills its online service as offering a “discreet and convenient” alternative to an in-person doctor visit, has just announced a $32 million Series A round, led by growth equity firm HPE Growth.

Zava relies on patients filling in an online medical questionnaire which is reviewed by a person from its team of in-house doctors/clinicians as part of the remote consultation process. Test kits and/or medicine can follow in the post or be sent to a pharmacy for the patient to collect.

“Zava provides reliable and convenient access to a qualified clinical team, via written communication, which drives an effective patient:doctor relationship,” says co-founder and CEO David Meinertz. “The questions

Read More At Article Source | Article Attribution